EAGAN, Minn.--(BUSINESS WIRE)--ATS Labs, Inc. announces the acquisition of Microcheck, Inc., a provider of contract microbial identification testing in strict accordance with Current Good Manufacturing Practices (cGMPs). “The acquisition of Microcheck strengthens ATS Labs’ microbiology services to sterile and non-sterile manufacturing operations. This positions our company as the premier comprehensive provider of microbiology services for industries that actively manage microbial environmental contamination,” says Brian C. Brosdahl, Ph.D., ATS Labs’ president and chief executive officer. As a leader in microbial identification of bacteria, fungi and yeasts, Microcheck supports environmental monitoring and quality control programs for the pharmaceutical, medical device, cosmetics, personal care, agriculture/food, raw materials, water testing, research, bioremediation and other related industries. The company’s expert scientific team uses state-of-the-art technologies for bacterial identification, fungal identification, gene sequencing, environmental monitoring and microbiology testing. Since 1988, Microcheck’s team has identified more than 500,000 isolates to species level.
